Harmony Biosciences

Employee size

201-500

Organization type

Public Company

Headquarters

Plymouth Meeting, PA

Founded

2017

Founded in 2017, Harmony Biosciences is a Plymouth Meeting pharmaceutical company developing and commercializing medicines for people living with rare neurological disorders. Its FDA-approved product, WAKIX (pitolisant), anchors a patient-focused research program spanning sleep/wake disorders and rare epilepsy, with patient insights informing clinical development. The company describes this approach as “Newrology,” combining empathy with innovation while expanding its pipeline and community support.

• Leadiant Biosciences, IncFrom its Rockville base, Leadiant Biosciences develops and distributes prescription therapies for people living with rare diseases. The private U.S. pharmaceutical company draws on a longstanding heritage in orphan-drug development, becoming the fourth company in the world to receive a U.S. Orphan Drug Designation in 1984. Its research teams work with physicians, researchers, academic institutions and biotechnology organizations, while patient-support programs provide education and resources beyond the medicine itself.ROCKVILLE, MD
• Gilgamesh PharmaGilgamesh Pharma is a New York clinical-stage neuroscience biotech developing novel chemical entities for psychiatric disease, with an emphasis on rapid-acting and durable therapies rather than symptom management alone. Its in-house discovery platform combines medicinal chemistry, neurocircuitry science, and computational modeling, and has produced clinical programs including blixeprodil and a neuroplastogen partnership with AbbVie. The company’s first clinical asset, bretisilocin, was acquired by AbbVie after advancing to Phase 2.New York, NY
• P2D BioscienceP2D Bioscience is a specialty pharmaceutical company developing drug candidates for inflammatory disorders of the central nervous system, with a pipeline aimed at frontotemporal dementia, Alzheimer’s disease and ADHD. Its approach combines targeted phenotypic screening with transgenic preclinical models, while its management brings deep experience in neuroscience, toxicology and early-stage drug development. The company advances candidates through preclinical and early clinical studies before seeking partners for later development and commercialization.CINCINNATI, OH
• TerSera Therapeutics LLCFounded in 2016, TerSera Therapeutics is a biopharmaceutical company that develops, commercializes, and supports medicines aimed at unmet patient needs. Based in Deerfield, the company combines clinical development expertise with a patient-focused approach and maintains a portfolio spanning oncology, rare disease, and non-opioid pain. Its support programs help patients and providers navigate access and treatment.DEERFIELD, IL